SANDRA SCHOLEBO: Open Payments
NPI 1437168622 · PORTAGE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,870 in 128 payments from 19 companies in 2025. Trend: 2023 $2,060 · 2024 $2,884 · 2025 $2,870
Food & beverage: $2,661Education: $209
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $469 |
| UCB, Inc. | 18 | $430 |
| Janssen Biotech, Inc. | 9 | $348 |
| Lilly USA, LLC | 15 | $286 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $215 |
| Regeneron Healthcare Solutions, Inc. | 6 | $207 |
| GENZYME CORPORATION | 8 | $186 |
| Incyte Corporation | 8 | $182 |
| Novartis Pharmaceuticals Corporation | 6 | $143 |
| Organon LLC | 7 | $136 |
Products named: Bimzelx, DUPIXENT, TREMFYA, SKYRIZI, EBGLYSS, OPZELURA, Leqselvi, ILUMYA.
Industry payments across IN — which companies pay providers there.
